Literature DB >> 9680619

Luminescence-based cell viability testing.

I A Cree1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9680619     DOI： 10.1385/0-89603-520-4:169

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  8 in total

1.  Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.

Authors:  S R Boyd; D S W Tan; L de Souza; M H Neale; N E Myatt; R A Alexander; M Robb; J L Hungerford; I A Cree
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.

Authors:  Laura R Bohrer; Ping Liu; Jian Zhong; Yunqian Pan; James Angstman; Lucas J Brand; Scott M Dehm; Haojie Huang
Journal:  Prostate       Date:  2013-02-06       Impact factor: 4.104

3.  The effect of pentamidine on melanoma ex vivo.

Authors:  Jason Smith; Benjamin J Stewart; Sharon Glaysher; Katharine Peregrin; Louise A Knight; David J Weber; Ian A Cree
Journal:  Anticancer Drugs       Date:  2010-02       Impact factor: 2.248

4.  Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy.

Authors:  S Glaysher; F G Gabriel; P Johnson; M Polak; L A Knight; K Parker; M Poole; A Narayanan; I A Cree
Journal:  Br J Cancer       Date:  2010-08-10       Impact factor: 7.640

5.  The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin.

Authors:  Wenting He; Dachuan Zhang; Jingting Jiang; Ping Liu; Changping Wu
Journal:  Med Oncol       Date:  2014-04-11       Impact factor: 3.064

6.  Cancer cell adaptation to chemotherapy.

Authors:  Federica Di Nicolantonio; Stuart J Mercer; Louise A Knight; Francis G Gabriel; Pauline A Whitehouse; Sanjay Sharma; Augusta Fernando; Sharon Glaysher; Silvana Di Palma; Penny Johnson; Shaw S Somers; Simon Toh; Bernie Higgins; Alan Lamont; Tim Gulliford; Jeremy Hurren; Constantinos Yiangou; Ian A Cree
Journal:  BMC Cancer       Date:  2005-07-18       Impact factor: 4.430

7.  Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC).

Authors:  Sharon Glaysher; Dennis Yiannakis; Francis G Gabriel; Penny Johnson; Marta E Polak; Louise A Knight; Zoe Goldthorpe; Katharine Peregrin; Mya Gyi; Paul Modi; Joe Rahamim; Mark E Smith; Khalid Amer; Bruce Addis; Matthew Poole; Ajit Narayanan; Tim J Gulliford; Peter E Andreotti; Ian A Cree
Journal:  BMC Cancer       Date:  2009-08-27       Impact factor: 4.430

8.  Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C.

Authors:  P A Whitehouse; S J Mercer; L A Knight; F Di Nicolantonio; A O'Callaghan; I A Cree
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.